Cargando…

What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia

INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Martin, Estefania, Vidmark, Jessica S. L., MacLean, Jennifer A., Sanger, Terence D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457157/
https://www.ncbi.nlm.nih.gov/pubmed/37638186
http://dx.doi.org/10.3389/fneur.2023.1215572
_version_ 1785096861414064128
author Hernandez-Martin, Estefania
Vidmark, Jessica S. L.
MacLean, Jennifer A.
Sanger, Terence D.
author_facet Hernandez-Martin, Estefania
Vidmark, Jessica S. L.
MacLean, Jennifer A.
Sanger, Terence D.
author_sort Hernandez-Martin, Estefania
collection PubMed
description INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on their effects on deep brain regions, nor on these regions’ responses to DBS. How the BDZ affects the thalamus and basal ganglia in dystonia patients remains unknown. METHODS: DBS recordings were performed in ventral oralis anterior/posterior (VoaVop), ventral intermediate (VIM) and ventral anterior (VA) thalamic subnuclei, as well as globus pallidus interna (GPi) and subthalamic nucleus (STN). Evoked potentials (EP) and frequency domain analysis were performed to determine the BDZ effect on neural activities compared to the control condition (off-BDZ). Three male pediatric patients with dystonia treated with BDZ and undergoing depth electrode evaluation for clinical targeting were recruited for the study. Stimulation was administered at 25 and 55 Hz frequencies and recordings were simultaneously gathered through pairs of externalized stereoelectroencephalography (sEEG) electrodes. EP amplitude and the effect of stimulation on the frequency spectrum of activity were compared at baseline and following clinical administration of BDZ. RESULTS: Frequency analysis showed consistent reductions in activity during BDZ treatment in all studied brain regions for all patients. Evoked potential (EP) analysis showed increased subthalamic nucleus (STN) EP amplitude and decreased ventral intermediate (VIM) and STN EP amplitude during BDZ treatment. INTERPRETATION: BDZs reduce thalamic and basal ganglia activity in multiple regions and alter the efficacy of transmission between these regions. While the mechanism is unknown our results confirm the known widespread effects of this class of medications and identify specific areas within the motor system that are directly affected.
format Online
Article
Text
id pubmed-10457157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104571572023-08-26 What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia Hernandez-Martin, Estefania Vidmark, Jessica S. L. MacLean, Jennifer A. Sanger, Terence D. Front Neurol Neurology INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on their effects on deep brain regions, nor on these regions’ responses to DBS. How the BDZ affects the thalamus and basal ganglia in dystonia patients remains unknown. METHODS: DBS recordings were performed in ventral oralis anterior/posterior (VoaVop), ventral intermediate (VIM) and ventral anterior (VA) thalamic subnuclei, as well as globus pallidus interna (GPi) and subthalamic nucleus (STN). Evoked potentials (EP) and frequency domain analysis were performed to determine the BDZ effect on neural activities compared to the control condition (off-BDZ). Three male pediatric patients with dystonia treated with BDZ and undergoing depth electrode evaluation for clinical targeting were recruited for the study. Stimulation was administered at 25 and 55 Hz frequencies and recordings were simultaneously gathered through pairs of externalized stereoelectroencephalography (sEEG) electrodes. EP amplitude and the effect of stimulation on the frequency spectrum of activity were compared at baseline and following clinical administration of BDZ. RESULTS: Frequency analysis showed consistent reductions in activity during BDZ treatment in all studied brain regions for all patients. Evoked potential (EP) analysis showed increased subthalamic nucleus (STN) EP amplitude and decreased ventral intermediate (VIM) and STN EP amplitude during BDZ treatment. INTERPRETATION: BDZs reduce thalamic and basal ganglia activity in multiple regions and alter the efficacy of transmission between these regions. While the mechanism is unknown our results confirm the known widespread effects of this class of medications and identify specific areas within the motor system that are directly affected. Frontiers Media S.A. 2023-08-11 /pmc/articles/PMC10457157/ /pubmed/37638186 http://dx.doi.org/10.3389/fneur.2023.1215572 Text en Copyright © 2023 Hernandez-Martin, Vidmark, MacLean and Sanger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Hernandez-Martin, Estefania
Vidmark, Jessica S. L.
MacLean, Jennifer A.
Sanger, Terence D.
What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title_full What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title_fullStr What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title_full_unstemmed What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title_short What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
title_sort what is the effect of benzodiazepines on deep brain activity? a study in pediatric patients with dystonia
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457157/
https://www.ncbi.nlm.nih.gov/pubmed/37638186
http://dx.doi.org/10.3389/fneur.2023.1215572
work_keys_str_mv AT hernandezmartinestefania whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia
AT vidmarkjessicasl whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia
AT macleanjennifera whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia
AT sangerterenced whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia